pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
[]
they screened 1364 - most screen fails were from inadequate tissue for stratification. about 82% underwent surgery - on par with other studies in this space. mostly lobectomy here. #asco23 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast, #ITYSL, #HereWeGo